DAP1-2: a synthetic peptide targeting IL-1R1 receptor effectively suppresses IL-1β in vitro

Patil KR and Patil CR. 2017. Anti-inflammatory activity of bartogenic acid containing fraction of fruits of Barringtonia racemosa Roxb. in acute and chronic animal models of inflammation. J Trad Complement Med. https://doi.org/10.1016/j.jtcme.2016.02.001.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X and Zhao L. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. https://doi.org/10.18632/oncotarget.23208.

Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20236008.

Article  PubMed  PubMed Central  Google Scholar 

Adams C, Conigrave JH, Lewohl J, Haber P, Morley KC. Alcohol use disorder and circulating cytokines: a systematic review and meta-analysis. Brain Behav Immun. 2020. https://doi.org/10.1016/j.bbi.2020.08.002.

Article  PubMed  Google Scholar 

Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007. https://doi.org/10.1097/AIA.0b013e318034194e.

Article  PubMed  PubMed Central  Google Scholar 

Tan JL, Lash B, Karami R, Nayer B, Lu YZ, Piotto C, Julier Z, Martino MM. Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist. Commun Biol. 2021. https://doi.org/10.1038/s42003-021-01913-9.

Article  PubMed  PubMed Central  Google Scholar 

Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, Polak L, Kulukian A, Chai S, Fuchs E. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017. https://doi.org/10.1038/nature24271.

Article  PubMed  PubMed Central  Google Scholar 

Nosenko MA, Ambaryan SG, Drutskaya MS. Proinflammatory cytokines and skin wound healing in mice. Mol Biol. 2019. https://doi.org/10.1134/S0026898419050136.

Article  Google Scholar 

Akash MSH, Rehman K, ChenS. IL-1RA and its delivery strategies: inserting the association in perspective. Pharm Res. 2013. https://doi.org/10.1007/s11095-013-1118-0.

Article  PubMed  Google Scholar 

Abbate A, Toldo S, Marchetti C, Kron J, Van-Tasseli BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020. https://doi.org/10.1161/CIRCRESAHA.120.315937.

Article  PubMed  PubMed Central  Google Scholar 

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006. https://doi.org/10.1038/nature05485.

Article  PubMed  Google Scholar 

Yan C, Gao N, Sun H, Yin J, Lee P, Zhou L, Fan X, Yu FS. Targeting imbalance between IL-1β and IL-1 receptor antagonist ameliorates delayed epithelium wound healing in diabetic mouse corneas. Am J Pathol. 2016. https://doi.org/10.1016/j.ajpath.2016.01.019.

Article  PubMed  PubMed Central  Google Scholar 

Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004. https://doi.org/10.1016/S1074-7613(04)00046-9.

Article  PubMed  Google Scholar 

Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009. https://doi.org/10.1146/annurev.immunol.021908.132612.

Article  PubMed  Google Scholar 

Walle LV, Opdenbosch NV, Jacques P, Fossoul A, Verheugen E, Vogel P, Beyaert R, Elewaut D, Kanneganti TV, Loo GV, Lamkanti M. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014. https://doi.org/10.1038/nature13322.

Article  PubMed Central  Google Scholar 

Dinarello CA, Van-Der-Meer JWM. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013. https://doi.org/10.1016/j.smim.2013.10.008.

Article  PubMed  PubMed Central  Google Scholar 

Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013. https://doi.org/10.1016/j.immuni.2013.11.010.

Article  PubMed  PubMed Central  Google Scholar 

Cavalli G, Dinarello CA. Anakinra therapy for non-cancer inflammatory diseases. Front Pharmacol. 2018. https://doi.org/10.3389/fphar.2018.01157.

Article  PubMed  PubMed Central  Google Scholar 

Stredny CM, Siobhan C, Sansevere AJ, Marybeth F, Henderson L, Gorman MP. Interleukin-6 blockade with tocilizumab in anakinra-refractory febrile infection- related epilepsy syndrome (FIRES). Child neurology open. 2020. https://doi.org/10.1177/2329048X20979253.

Article  PubMed  PubMed Central  Google Scholar 

Somagutta MKR, Pormento MKL, Hamid P, Hamdan A, Khan MA, Desir R, Vijayan R, Shirke S, Jeyakumar R, Dogar Z, Makkar SS, Guntipalli P, Ngardig NN, Nagineni MS, Paul T, Luvsannyam E, Riddick C, Sanchez-Gonzalez MA. The safety and efficacy of anakinra, an interleukin-1 antagonist in severe cases of COVID-19: a systematic review and meta-analysis. J Infect Chemother. 2021. https://doi.org/10.3947/ic.2021.0016.

Article  Google Scholar 

Klementiev B, Li S, Korshunova I, Dmytriyeva O, Pankratova S, Walmod PS, Kjær LK, Dahllöf MS, Lundh M, Christensen DP, Mandrup-Poulsen T, Bock E, Berezin V. Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist. J Neuroinflammation. 2014. https://doi.org/10.1186/1742-2094-11-27.

Article  PubMed  PubMed Central  Google Scholar 

Machado-de-Ávila RA, Velloso M, Oliveira D, Stransky S, Flor-Sá A, Schneider FS, Neshich G, Chávez-Olórtegui C. Induction of neutralizing antibodies against mutalysin-II from Lachesis muta muta snake venom elicited by a conformational B cell epitope predicted by Blue Star Sting data base. Immunome Res. 2014. https://doi.org/10.4172/1745-7580.1000083.

Article  Google Scholar 

Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997. https://doi.org/10.1002/elps.1150181505.

Article  PubMed  Google Scholar 

Merrifield RB. Solid-phase peptide synthesis. Adv Enzymol Relat Areas Mol Biol. 1969. https://doi.org/10.1002/0471140864.ps1801s26.

Article  PubMed  Google Scholar 

Martin P, Goldstein JD, Mermoud L, Diaz-Barreiro A, Palmer G. IL-1 family antagonists in mouse and human skin inflammation. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.652846.

Article  PubMed  PubMed Central  Google Scholar 

Supino D, Minute L, Mariancini A, Riva F, Magrini E, Garlanda C. Negative regulation of the IL-1 system by IL-1R2 and IL-1R8: relevance in pathophysiology and disease. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.804641.

Article  PubMed  PubMed Central  Google Scholar 

Kluczyk A, Siemiona IZ, Wieczorek Z. The “two-headed” peptide inhibitors of interleukin-1 action. Peptides. 2000. https://doi.org/10.1016/s0196-9781(00)00285-0.

Article  PubMed  Google Scholar 

Barkestani MN, Naserian S, Khoddam F, Shamdani S, Bambai B. Optimization of IL-1RA structure to achieve a smaller protein with a higher affinity to its receptor. Sci Rep. 2022. https://doi.org/10.1038/s41598-022-11100-3.

Article  Google Scholar 

Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Rw B. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 2001. https://doi.org/10.1038/386194a0.

Article  Google Scholar 

Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J. The role of interleukin- 1 in general pathology. Inflamm Regen. 2019. https://doi.org/10.1186/s41232-019-0101-5.

Article  PubMed  PubMed Central  Google Scholar 

Rider P, Carmi Y, Yossef R, Guttman O, Eini H, Azam T, Dinarello CA, Lewis EC. IL-1 receptor antagonist chimeric protein: context-specific and inflammation-restricted activation. J Immunol. 2015. https://doi.org/10.4049/jimmunol.1501168.

Article  PubMed  Google Scholar 

Oliviero F, Sfriso P, Punzi L, Dayer JM. Editorial: IL-1 inhibition. Front Pharmacol. 2019. https://doi.org/10.3389/fphar.2019.00087.

Article  PubMed  PubMed Central  Google Scholar 

Ozen G, Pedro S, England BR, Mehta B, Wolfe F, Michaud K. Risk of serious infection in patients with rheumatoid arthritis treated with biologic versus nonbiologic disease-modifying antirheumatic drugs. ACR Open Rheumatol. 2019. https://doi.org/10.1002/acr2.11064.

Article  PubMed  PubMed Central  Google Scholar 

Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM. Development of peptide biopharmaceuticals in Russia. Pharmaceutics. 2022. https://doi.org/10.3390/pharmaceutics14040716.

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif